|
1
|
Szakács G, Paterson JK, Ludwig JA, et al:
Targeting multidrug resistance in cancer. Nat Rev Drug Discov.
5:219–234. 2006.
|
|
2
|
Zhang K, Mack P and Wong KP:
Glutathione-related mechanisms in cellular resistance to anticancer
drugs. Int J Oncol. 12:871–882. 1998.PubMed/NCBI
|
|
3
|
Johnstone RW, Ruefli AA and Lowe SW:
Apoptosis: a link between cancer genetics and chemotherapy. Cell.
108:153–164. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rabik CA and Dolan ME: Molecular
mechanisms of resistance and toxicity associated with platinating
agents. Cancer Treat Rev. 33:9–23. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fojo T: Multiple paths to a drug
resistance phenotype: mutations, translocations, deletions and
amplification of coding genes or promoter regions, epigenetic
changes and microRNAs. Drug Resist Updat. 10:59–67. 2007.
View Article : Google Scholar
|
|
6
|
Glasspool RM, Teodoridis JM and Brown R:
Epigenetics as a mechanism driving polygenic clinical drug
resistance. Br J Cancer. 94:1087–1092. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sharma SV, Lee DY, Li B, et al: A
chromatin-mediated reversible drug-tolerant state in cancer cell
subpopulations. Cell. 141:69–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee RC, Feinbaum RL and Ambros V: The
C. elegans heterochronic gene lin-4 encodes small RNAs with
antisense complementarity to lin-14. Cell. 75:843–854. 1993.
|
|
9
|
Garzon R, Marcucci G and Croce CM:
Targeting microRNAs in cancer: rationale, strategies and
challenges. Nat Rev Drug Discov. 9:775–789. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen GQ, Zhao ZW, Zhou HY, et al:
Systematic analysis of microRNA involved in resistance of the MCF-7
human breast cancer cell to doxorubicin. Med Oncol. 27:406–415.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bourguignon LY, Spevak CC, Wong G, et al:
Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes
oncogenic signaling by the stem cell marker Nanog and the
production of microRNA-21, leading to down-regulation of the tumor
suppressor protein PDCD4, anti-apoptosis, and chemotherapy
resistance in breast tumor cells. J Biol Chem. 284:26533–26546.
2009.
|
|
12
|
Li Y, Li W, Yang Y, et al: MicroRNA-21
targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma
multiforme. Brain Res. 1286:13–18. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu K, Liang X, Cui D, et al: miR-1915
inhibits Bcl-2 to modulate multidrug resistance by increasing
drug-sensitivity in human colorectal carcinoma cells. Mol Carcinog.
52:70–78. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xia L, Zhang D, Du R, et al: miR-15b and
miR-16 modulate multidrug resistance by targeting BCL2 in human
gastric cancer cells. Int J Cancer. 123:372–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen J, Tian W, Cai H, et al:
Down-regulation of microRNA-200c is associated with drug resistance
in human breast cancer. Med Oncol. 29:2527–2534. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou J and Wang W: Analysis of microRNA
expression profiling identifies microRNA-503 regulates metastatic
function in hepatocellular cancer cell. J Surg Oncol. 104:278–283.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lu YC, Chen YJ, Wang HM, et al: Oncogenic
function and early detection potential of miRNA-10b in oral cancer
as identified by microRNA profiling. Cancer Prev Res (Phila).
5:665–674. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Özata DM, Caramuta S, Velázquez-Fernández
D, et al: The role of microRNA deregulation in the pathogenesis of
adrenocortical carcinoma. Endocr Relat Cancer. 18:643–655.
2011.PubMed/NCBI
|
|
19
|
Corbetta S, Vaira V, Guarnieri V, et al:
Differential expression of microRNAs in human parathyroid
carcinomas compared with normal parathyroid tissue. Endocr Relat
Cancer. 17:135–146. 2010. View Article : Google Scholar
|
|
20
|
Zhao JJ, Yang J, Lin J, et al:
Identification of miRNAs associated with tumorigenesis of
retinoblastoma by miRNA microarray analysis. Childs Nerv Syst.
25:13–20. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cui YH, Xiao L, Rao JN, et al: miR-503
represses CUG-binding protein 1 translation by recruiting CUGBP1
mRNA to processing bodies. Mol Biol Cell. 23:151–162. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jiang Q, Feng MG and Mo YY: Systematic
validation of predicted microRNAs for cyclin D1. BMC Cancer.
9:1942009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cheng G, Sun S, Wang Z and Jin S:
Investigation of the interaction between the miR-503 and CD40 genes
in irradiated U937 cells. Radiat Oncol. 7:382012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhu W, Zhu D, Lu S, et al: miR-497
modulates multidrug resistance of human cancer cell lines by
targeting BCL2. Med Oncol. 29:384–391. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yamaue H, Tanimura H, Noguchi K, et al:
Chemosensitivity testing of fresh human gastric cancer with highly
purified tumor cells using the MTT assay. Br J Cancer. 66:794–799.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamaue H, Tani M, Onishi H, et al:
Locoregional chemotherapy for patients with pancreatic cancer
intra-arterial adjuvant chemotherapy after pancreatectomy with
portal vein resection. Pancreas. 25:366–372. 2002. View Article : Google Scholar
|
|
28
|
Wang S, Yang D and Lippman ME: Targeting
Bcl-2 and Bcl-XL with nonpeptidic small-molecule antagonists. Semin
Oncol. 30(Suppl 16): S133–S142. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Reed JC: Drug insight: cancer therapy
strategies based on restoration of endogenous cell death
mechanisms. Nat Clin Prac Oncol. 3:388–398. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tanida S, Mizoshita T, Ozeki K, et al:
Mechanisms of cisplatin-induced apoptosis and of cisplatin
sensitivity: potential of BIN1 to act as a potent predictor of
cisplatin sensitivity in gastric cancer treatment. Int J Surg
Oncol. 2012:8628792012.PubMed/NCBI
|
|
31
|
Beale PJ, Rogers P, Boxall F, et al: BCL-2
family protein expression and platinum drug resistance in ovarian
carcinoma. Br J Cancer. 82:436–440. 2000.PubMed/NCBI
|
|
32
|
Yu L and Wang Z: Difference in expression
of Bcl-2 and Bcl-xl genes in cisplatin-sensitive and
cisplatin-resistant human in ovarian cancer cell lines. J Huazhong
Univ Sci Technolog Med Sci. 24:151–153. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dong Z and Wang J: Hypoxia selection of
death-resistant cells. A role for Bcl-X(L). J Biol Chem.
279:9215–9221. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Williams J, Lucas PC, Griffith KA, et al:
Expression of Bcl-xL in ovarian carcinoma is associated with
chemoresistance and recurrent disease. Gynecol Oncol. 96:287–295.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhu W, Shan X, Wang TS, et al: miR-181b
modulates multidrug resistance by targeting BCL2 in human cancer
cell lines. Int J Cancer. 127:2520–2529. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Baylin SB: DNA methylation and gene
silencing in cancer. Nat Clin Pract Oncol. 2(Suppl 1): S4–S11.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li D, Zhao Y, Liu C, et al: Analysis of
MiR-195 and MiR-497 expression, regulation and role in breast
cancer. Clin Cancer Res. 17:1722–1730. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Saito Y, Liang G, Egger G, et al: Specific
activation of microRNA-127 with downregulation of the
proto-oncogene BCL6 by chromatin-modifying drugs in human cancer
cells. Cancer Cell. 9:435–443. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Datta J, Kutay H, Nasser MW, et al:
Methylation mediated silencing of MicroRNA-1 gene and its role in
hepatocellular carcinogenesis. Cancer Res. 68:5049–5058. 2008.
View Article : Google Scholar : PubMed/NCBI
|
